533 related articles for article (PubMed ID: 17400043)
1. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
Rochira V; Zirilli L; Madeo B; Aranda C; Caffagni G; Fabre B; Montangero VE; Roldan EJ; Maffei L; Carani C
Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043
[TBL] [Abstract][Full Text] [Related]
2. Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men.
Khosla S; Melton LJ; Robb RA; Camp JJ; Atkinson EJ; Oberg AL; Rouleau PA; Riggs BL
J Bone Miner Res; 2005 May; 20(5):730-40. PubMed ID: 15824845
[TBL] [Abstract][Full Text] [Related]
3. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters.
Rochira V; Faustini-Fustini M; Balestrieri A; Carani C
J Clin Endocrinol Metab; 2000 May; 85(5):1841-5. PubMed ID: 10843162
[TBL] [Abstract][Full Text] [Related]
4. Low width of tubular bones is associated with increased risk of fragility fracture in elderly men--the MINOS study.
Szulc P; Munoz F; Duboeuf F; Marchand F; Delmas PD
Bone; 2006 Apr; 38(4):595-602. PubMed ID: 16249130
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-specific action on bone geometry and volumetric bone density: longitudinal observations in an adult with complete androgen insensitivity.
Taes Y; Lapauw B; Vandewalle S; Zmierczak H; Goemaere S; Vanderschueren D; Kaufman JM; T'Sjoen G
Bone; 2009 Aug; 45(2):392-7. PubMed ID: 19376280
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment.
Lanfranco F; Zirilli L; Baldi M; Pignatti E; Corneli G; Ghigo E; Aimaretti G; Carani C; Rochira V
Bone; 2008 Sep; 43(3):628-35. PubMed ID: 18590994
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: the GOOD study.
Lorentzon M; Swanson C; Eriksson AL; Mellström D; Ohlsson C
J Bone Miner Res; 2006 Feb; 21(2):332-9. PubMed ID: 16418790
[TBL] [Abstract][Full Text] [Related]
8. Skeletal changes in transgenic male mice expressing human cytochrome p450 aromatase.
Peng Z; Li X; Mäkelä S; Väänänen HK; Poutanen M
J Bone Miner Res; 2004 Aug; 19(8):1320-8. PubMed ID: 15231020
[TBL] [Abstract][Full Text] [Related]
9. Body composition, volumetric and areal bone parameters in male-to-female transsexual persons.
Lapauw B; Taes Y; Simoens S; Van Caenegem E; Weyers S; Goemaere S; Toye K; Kaufman JM; T'Sjoen GG
Bone; 2008 Dec; 43(6):1016-21. PubMed ID: 18835591
[TBL] [Abstract][Full Text] [Related]
10. The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat model.
Vandenput L; Swinnen JV; Van Herck E; Verstuyf A; Boonen S; Bouillon R; Vanderschueren D
Calcif Tissue Int; 2002 Mar; 70(3):170-5. PubMed ID: 11907714
[TBL] [Abstract][Full Text] [Related]
11. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
Wickman S; Kajantie E; Dunkel L
J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
[TBL] [Abstract][Full Text] [Related]
12. Bone metabolism in men: role of aromatase activity.
Nuti R; Martini G; Merlotti D; De Paola V; Valleggi F; Gennari L
J Endocrinol Invest; 2007; 30(6 Suppl):18-23. PubMed ID: 17721069
[TBL] [Abstract][Full Text] [Related]
13. Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency.
Herrmann BL; Janssen OE; Hahn S; Broecker-Preuss M; Mann K
Horm Metab Res; 2005 Mar; 37(3):178-83. PubMed ID: 15824973
[TBL] [Abstract][Full Text] [Related]
14. Serum estradiol is associated with volumetric BMD and modulates the impact of physical activity on bone size at the age of peak bone mass: a study in healthy male siblings.
Lapauw BM; Taes Y; Bogaert V; Vanbillemont G; Goemaere S; Zmierczak HG; De Bacquer D; Kaufman JM
J Bone Miner Res; 2009 Jun; 24(6):1075-85. PubMed ID: 19113912
[TBL] [Abstract][Full Text] [Related]
15. Turner syndrome and osteoporosis: mechanisms and prognosis.
Rubin K
Pediatrics; 1998 Aug; 102(2 Pt 3):481-5. PubMed ID: 9685448
[TBL] [Abstract][Full Text] [Related]
16. Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats.
Yarrow JF; Conover CF; Purandare AV; Bhakta AM; Zheng N; Conrad B; Altman MK; Franz SE; Wronski TJ; Borst SE
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1213-22. PubMed ID: 18780767
[TBL] [Abstract][Full Text] [Related]
17. The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency.
Zirilli L; Maffei L; Meunier PJ; Chavassieux P; Carani C; Rochira V
Bone; 2009 Nov; 45(5):827-32. PubMed ID: 19345749
[TBL] [Abstract][Full Text] [Related]
18. Sex steroids and sexual desire in a man with a novel mutation of aromatase gene and hypogonadism.
Carani C; Granata AR; Rochira V; Caffagni G; Aranda C; Antunez P; Maffei LE
Psychoneuroendocrinology; 2005 Jun; 30(5):413-7. PubMed ID: 15721053
[TBL] [Abstract][Full Text] [Related]
19. Effect of protein supplementation during a 6-month strength and conditioning program on areal and volumetric bone parameters.
Ballard TL; Specker BL; Binkley TL; Vukovich MD
Bone; 2006 Jun; 38(6):898-904. PubMed ID: 16364710
[TBL] [Abstract][Full Text] [Related]
20. Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study.
Lorentzon M; Swanson C; Andersson N; Mellström D; Ohlsson C
J Bone Miner Res; 2005 Aug; 20(8):1334-41. PubMed ID: 16007330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
